Lipocine Inc (NASDAQ:LPCN)

1.22
Delayed Data
As of 4:00pm ET
 -0.03 / -2.40%
Today’s Change
1.03
Today|||52-Week Range
5.33
-64.53%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close1.25
Today’s open1.25
Day’s range1.22 - 1.27
Volume110,333
Average volume (3 months)557,461
Market cap$27.0M
Data as of 4:00pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)-0.96%
Earnings growth (this year)+13.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc+0.01+1.89%
CEMIChembio Diagnostics ...+0.05+0.56%
AGTCApplied Genetic Tech...-0.30-5.31%
MRNSMarinus Pharmaceutic...+0.12+2.50%
Data as of 4:00pm ET, 05/22/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$21.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Secretary, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts